一般社団法人JBCRG学会発表
2024年
Fertility preservation and assisted reproductive technologies in breast cancer patients interrupting adjuvant endocrine therapy to attempt pregnancy
Hatem A Azim Jr, Samuel M Niman, Ann H Partridge, Isabelle Demeestere, Monica Ruggeri, Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna B Saetersdal, Judith R Kroep, Audrey Mailliez, Ellen Warner, Virginia F Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset-Jablonski, Simona Borstnar, Junko Takei, Jeong E Lee, Janice M Walshe, Manuel Ruíz-Borrego, Halle C F Moore, Christobel Saunders, Vesna Bjelic-Radisic, Snezana Susnjar, Fatima Cardoso, Natalie J Klar, Tanja Spanic, Kathryn Ruddy, Martine Piccart, Larissa A Korde, Aron Goldhirsch †, Richard D Gelber, Olivia Pagani, Fedro A Peccatori
San Antonio Breast Cancer Symposium, 2024 Dec, Texas, USA (Oral)
Does postmastectomy radiotherapy in ‘intermediate-risk’ breast cancer impact overall survival? 10 year results of the BIG 2-04 MRC randomized trial on behalf of the SUPREMO trial investigators
Ian Kunkler
San Antonio Breast Cancer Symposium, 2024 Dec, Texas, USA (Oral)
進行・再発乳癌患者・家族の支援に対する看護職の困難感の実態(TEPPICH-ABC)
Chie Watanabe, Chikako Shimizu, Naomi Sakurai, Yoshiaki Kamei, Yuichiro Kikawa, Shigehira Saji, Yuko Takeishi, Yoshie Hasegawa, Megumi Matsumoto, Norikazu Masuda
第62回日本癌治療学会学術集会, 2024 Oct, Fukuoka, Japan (Oral)
Treatment satisfaction in patients with HR+/HER2- advanced breast cancer in Japan treated with palbociclib+endocrine therapy (ET) or ET alone: 6-month longitudinal study (JBCRG-26)
Mihoko Doi, Hiroko Bando, Mari S. Oba, Aya Ueda, Kaori Terata, Shigenori Nagai, Masaya Hattori, Kenichi Watanabe, Nobuko Tamura, Naoki Niikura, Tempei Miyaji, Asuka Matsui, Linghua Xu, Norikazu Masuda, Shigehira Saji
第62回日本癌治療学会学術集会, 2024 Oct, Fukuoka, Japan (Oral)
Examining the association between patient-reported outcomes and physical activity metricsin patients with HR+/HER2 advanced breast cancer treated with palbociclib plus endocrine therapy or endocrine therapy alone
Mari S. Oba, Tempei Miyaji, Hiroko Bando, Aya Ueda, Kaori Terata, Mihoko Doi, Shigenori Nagai, Masaya Hattori, Kenichi Watanabe, Nobuko Tamura, Manabu Futamura, Kei Koizumi, Naoki Niikura, Yasuaki Muramatsu, Linghua Xu, Asuka Matsui, Norikazu Masuda, Shigehira Saji
The International Society for Quality of Life Research (ISOQOL) Annual Conference, 2024 Oct, Cologne, Germany (Oral)
Biomarkers for Palbociclib in Fulvestrant-Resistant Metastatic Breast Cancer Using cfDNA Cancer Panel Sequencing
Takashi Takeshita, Takayuki Iwamoto, Naoki Niikura, Kenichi Watanabe, Yuichiro Kikawa, Kokoro Kobayashi, Nobutaka Iwakuma, Takuho Okamura, Hiroshi Tada, Shinji Ozaki, Toshitaka Okuno, Uhi Toh, Yutaka Yamamoto, Michiko Tsuneizumi, Hiroshi Ishiguro, Norikazu Masuda, Shigehira Saji
第83回日本癌学会学術総会, 2024 Sep, Fukuoka, Japan (AACRアンコール、Oral）
Quality-of-life outcomes in patients with HER2-positive, locally advanced or metastatic breast cancer treated with eribulin mesylate in combination with trastuzumab and pertuzumab in the phase 3 JBCRG-M06/EMERALD study
Norikazu Masuda, Shigehira Saji, Tsuguo Iwatani, Toshimi Takano, Kei Koizumi, Yasuaki Sagara, Yoichi Naito, Michiko Tsuneizumi, Akiyo Yoshimura, Masato Takahashi, Junji Tsurutani, Masahiro Kitada, Hiroshi Tada, Toru Higuchi, Yasuyuki Kojima, Takayuki Kadoya, Hiroki Hasegawa, Yohei Uchida, Satoshi Morita, Toshinari Yamashita
ESMO, 2024 Sep, Barcelona, Spain (Poster)
Interim Analysis of Prospective Observational Study to Evaluate the Impact of Cancer Gene Panel Tests on Treatment Decision Making in Metastatic or Recurrent Breast Cancer in Japan: JBCRG-C07 REIWA Study1)
Hiroko Masuda, Hiroshi Tada, Masaya Hattori, Yasuaki Sagara, Yayoi Adachi, Tsuguo, Iwatani, Yasuaki Uemoto, Yoko Otani, Yukiko Kajiwara, Dai Kitagawa, Takahiro Kogawa, Tadahiko Shien, Yuko Tanabe, Maki Tanioka, Fumikata Hara, Hiroyuki Yasojima, Kenichi Yoshimura, Hiroji Iwata, Norikazu Masuda
ESMO, 2024 Sep, Barcelona, Spain (Poster)
パルボシクリブ投与時の有害事象ならびに病勢進行が健康関連QOLに及ぼす影響：前向き観察研究（JBCRG-26）
寺田かおり、坂東裕子、大庭真梨、上田文、尾崎慎治、永井成勲、服部正也、渡邊 健一、田村宜子、二村学、小泉圭、枝園忠彦、小林隆之、森奈採子、新倉直樹、宮路天平、村松泰明、徐凌華、増田慎三、佐治重衡
第32回日本乳癌学会学術総会, 2024 Jul, Sendai Japan (ポスター）
パルボシクリブ併用療法がQOLおよび身体活動量に及ぼす影響を評価した前向き観察研究（JBCRG-26）：主解析結果
上田文、 坂東裕子、大庭真梨、寺田かおり、尾崎慎治、永井成勲、服部正也、渡邊 健一、田村宜子、二村学、小泉圭、枝園忠彦、小林隆之、森奈採子、新倉直樹、宮路天平、村松泰明、徐凌華、増田慎三、佐治重衡
第32回日本乳癌学会学術総会, 2024 Jul, Sendai Japan (Oral）